Viewing data from:

AMLODIPINE BESYLATE

ANDA

AMLODIPINE BESYLATE | A077955 | INVAGEN PHARMACEUTICALS INC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: NORVASC(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 6 NDCs

Highest NADAC/Unit

$0.0152

per ea

Lowest NADAC/Unit

$0.0102

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
68645051654AMLODIPINE BESYLATE 10 MG TAB	$0.0152	EA	Generic	—	2026-06-17
76282023910AMLODIPINE BESYLATE 10 MG TAB	$0.0152	EA	Generic	—	2026-06-17
76282023990AMLODIPINE BESYLATE 10 MG TAB	$0.0152	EA	Generic	—	2026-06-17
68645051554AMLODIPINE BESYLATE 5 MG TAB	$0.0102	EA	Generic	—	2026-06-17
76282023810AMLODIPINE BESYLATE 5 MG TAB	$0.0102	EA	Generic	—	2026-06-17
76282023890AMLODIPINE BESYLATE 5 MG TAB	$0.0102	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$2.04

Highest Price

$22.77

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
76282-0237-10AMLODIPINE BESYLATE 2.5MG TAB	$22.77	FSS	Exelan Pharmaceuticals, Inc.	09/14/2026
76282-0237-90AMLODIPINE BESYLATE 2.5MG TAB	$2.04	FSS	Exelan Pharmaceuticals, Inc.	09/14/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain20 active DMFs14 inactive

19 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVAMLODIPINE BESYLATE

DMF 157772001

CADILA PHARMACEUTICALS LTDAMLODIPINE BESYLATE USP

DMF 169112003

CIPLA LTDAMLODIPINE BESYLATE USP

DMF 170322003

HETERO DRUGS LTDAMLODIPINE BESYLATE

DMF 187872005

APITORIA PHARMA PRIVATE LTDAMLODIPINE BESYLATE USP

DMF 189652005

ORBION PHARMACEUTICALS PRIVATE LTDAMLODIPINE BESYLATE

DMF 195822006

GLOCHEM INDUSTRIES PRIVATE LTDAMLODIPINE BESYLATE

DMF 195912006

MATRIX PHARMACORP PRIVATE LTDAMLODIPINE BESYLATE USP

DMF 201122007

SRINI PHARMACEUTICALS PRIVATE LTDAMLODIPINE BESYLATE USP

DMF 226222009

ZYDUS LIFESCIENCES LTDAMLODIPINE BESYLATE USP

DMF 229302009

NOVARTIS PHARMACEUTICALS CORPAMLODIPINE BESYLATE (PROCESS 2)

DMF 229642009

IPCA LABORATORIES LTDAMLODIPINE BESYLATE USP

DMF 235892010

ARCH PHARMALABS LTDAMLODIPINE BESYLATE USP

DMF 236322010

GLOCHEM INDUSTRIES PRIVATE LTDAMLODIPINE BESYLATE (PROCESS 1)

DMF 278102013

ZHEJIANG HUAHAI PHARMACEUTICAL CO LTDAMLODIPINE BESYLATE USP

DMF 288862015

ALKEM LABORATORIES LTDAMLODIPINE BESYLATE USP

DMF 297032015

AURORE LIFE SCIENCES PRIVATE LTDAMLODIPINE BESYLATE USP

DMF 343182019

ARENE LIFE SCIENCES PRIVATE LTDAMLODIPINE BESYLATE USP (PROCESS-I)

DMF 359972021

UNICHEM LABORATORIES LTDAMLODIPINE BESYLATE (ADP PROCESS) USP

DMF 404382024

LEE PHARMA LIMITEDAMLODIPINE BESYLATE

DMF 437012026

MATRIX LABORATORIES LTDInactiveAMLODIPINE

DMF 165962003

LEK PHARMACEUTICALS DDInactiveAMLODIPINE BESYLATE

DMF 168872003

MYLAN LABORATORIES LTDInactiveAMLODIPINE BESYLATE USP (ADP)

DMF 172112004

GEDEON RICHTER LTDInactiveAMLODIPINE BESYLATE

DMF 175842004

SYNTHON BVInactiveAMLODIPINE BESYLATE MONOHYDRATE

DMF 188722005

EOS ECZACIBASI OZGUN KIMYASAL URUNLER SANAYI VE TICARET ASInactiveAMLODIPINE BESYLATE

DMF 202772007

CHANGZHOU RUIMING PHARMACEUTICAL CO LTDInactiveAMLODIPINE BESYLATE (NON-STERILE DRUG SUBSTANCE)

DMF 212562008

ALP PHARM BEIJING CO LTDInactiveAMLODIPINE BESYLATE (DRUG SUBSTANCE, NON-STERILE)

DMF 219512008

ESTEVE QUIMICA SAInactiveAMLODIPINE BESYLATE

DMF 223422008

SHANDONG XINHUA PHARMACEUTICAL CO LTDInactiveAMLODIPINE BESYLATE

DMF 261322012

EGIS PHARMACEUTICALS PRIVATE LTD COInactiveAMLODIPINE BESYLATE API

DMF 279642014

TEVA PHARMACEUTICAL INDUSTRIES LTDInactiveAMLODIPINE BESYLATE (PROCESS II)

DMF 283512014

HETERO DRUGS LTDInactiveAMLODIPINE BESYLATE (PROCESS-II)

DMF 307172016

ARENE LIFE SCIENCES PVT LTDInactiveAMLODIPINE BESYLATE USP

DMF 338732019

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — EQ 2.5MG BASE

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Aug 28, 2007

No patent or exclusivity listings for this strength.

#002 — EQ 5MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Aug 28, 2007

#003 — EQ 10MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Aug 28, 2007